BrightHeart View Classifier vs CardioLogs ECG Analysis Platform

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by BrightHeart
VS
by CardioLogs (acquired by Philips in 2021)

AI Verdict

Tool A, BrightHeart View Classifier, is designed for AI-powered guidance and analysis of prenatal ultrasound exams to enhance the detection of congenital heart defects. In contrast, Tool B, CardioLogs ECG Analysis Platform, leverages AI and cloud technology for the rapid and accurate analysis of ECG data to aid in arrhythmia detection and diagnosis. While both are cardiology AI tools, their distinct input data (ultrasound images vs. ECG data) and specific clinical applications mean they address different diagnostic needs within cardiology.

Choose BrightHeart View Classifier if…

Choose BrightHeart View Classifier if your practice specializes in maternal-fetal medicine or obstetrics and gynecology and requires real-time AI guidance during prenatal ultrasound exams. This tool is ideal for enhancing the detection of congenital heart defects and ensuring comprehensive, consistent fetal heart screenings, ultimately reducing incomplete scans and patient recalls.

View BrightHeart View Classifier →

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your primary need is rapid and accurate AI-powered analysis of ECG data from a wide range of cardiac monitoring devices, including Holter, smartwatches, and ECG patches. This platform is best suited for efficiently detecting and diagnosing arrhythmias across various patient populations, streamlining cardiology diagnostics and integration with EHR systems.

View CardioLogs ECG Analysis Platform →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature BrightHeart View Classifier CardioLogs ECG Analysis Platform
Deployment Seamless integration into existing ultrasound workflows, plug and play solution, compatible with major ultrasound manufacturers and existing reporting solutions, automatic display on cart-side tablet during scan, results summarized and linked in reporting software, detailed assessments on standalone web platform. Cloud-based
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

BrightHeart View Classifier

BrightHeart View Classifier offers real-time guidance via a cart-side tablet, seamlessly integrating into existing ultrasound workflows as a plug-and-play solution. This direct, interactive support during a complex procedure provides an immediate and tangible usability advantage for sonographers during the examination itself.

Clinical Value

BrightHeart View Classifier

Both tools offer significant clinical value, but BrightHeart View Classifier addresses a critical unmet need by enhancing the detection of congenital heart defects (CHDs) during prenatal ultrasounds, a task with historically high rates of missed diagnoses. Its ability to ensure exam completeness and consistency, regardless of operator experience, and its high sensitivity and specificity for CHD detection, provide a transformative impact on prenatal care.

Pricing & Value

CardioLogs ECG Analysis Platform

CardioLogs ECG Analysis Platform offers a transparent pricing model of 'Pay per ECG regardless of the number of users,' which provides a clear basis for understanding costs and assessing value. In contrast, BrightHeart View Classifier does not publicly disclose any pricing information, making it impossible to evaluate its value proposition without direct inquiry.

Enterprise Readiness

CardioLogs ECG Analysis Platform

CardioLogs ECG Analysis Platform explicitly states HIPAA compliance, ISO/IEC 27001 certification for secure hosting, and integration with EHR systems, which are essential for enterprise adoption. Being part of Philips further enhances its credibility and support infrastructure. BrightHeart View Classifier lacks explicit public statements on HIPAA compliance and Business Associate Agreements (BAA), which are crucial for healthcare enterprises.

Innovation

BrightHeart View Classifier

BrightHeart View Classifier's real-time, interactive guidance delivered via a cart-side tablet during live fetal ultrasound examinations for complex heart view detection is a highly innovative application of AI. Furthermore, its FDA approval for a Predetermined Change Control Plan (PCCP) allows for efficient future AI improvements without separate FDA submissions, demonstrating an innovative approach to regulatory compliance and continuous product enhancement.

Support & Docs

CardioLogs ECG Analysis Platform

CardioLogs ECG Analysis Platform provides clear avenues for customer and technical support, including a dedicated Support Center, product manuals, and access to various white papers and clinical articles. BrightHeart View Classifier does not publicly provide information regarding customer support channels or readily available product documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature BrightHeart View Classifier CardioLogs ECG Analysis Platform
Name BrightHeart View Classifier CardioLogs ECG Analysis Platform
Company BrightHeart Cardiologs Technologies (now part of Philips)
Primary Function AI-powered guidance and analysis for prenatal ultrasound exams, enhancing the detection of congenital heart defects and ensuring exam completeness. Uses medical-grade AI and cloud technology for rapid, accurate, and efficient analysis of ECG data from various cardiac monitoring devices, aiding physicians in arrhythmia detection and diagnosis.
Key AI Application AI-powered analysis of fetal heart ultrasound exams; Automatic detection and confirmation of standard fetal heart views; Flags potential structural abnormalities suggestive of congenital heart defects. AI-Powered ECG Analysis (Deep Neural Networks); Automated Arrhythmia Detection (e.g., AFib, VT).
Target Medical Specialties Cardiology, Maternal-Fetal Medicine, Obstetrics & Gynecology Cardiology, Emergency Medicine, Internal Medicine
Integration Capabilities Seamless integration into existing ultrasound workflows as a plug-and-play solution; Compatible with major ultrasound manufacturers and existing reporting solutions. Integration with EHR Systems; Multi-Device Compatibility (Holter, smartwatches, ECG patches).

Videos

Demos, reviews, and walkthroughs featuring BrightHeart View Classifier and CardioLogs ECG Analysis Platform.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

BrightHeart View Classifier provides real-time AI-powered guidance during prenatal ultrasound exams via a cart-side tablet, assisting sonographers during the live scan. In contrast, CardioLogs ECG Analysis Platform offers rapid, accurate analysis of ECG data after acquisition from various cardiac monitoring devices.
BrightHeart View Classifier is compatible with major ultrasound manufacturers and existing reporting solutions, with results summarized and linked in reporting software. CardioLogs ECG Analysis Platform explicitly integrates with EHR systems and can interface with other computer-based ECG management systems, facilitating comprehensive data flow.
BrightHeart View Classifier enhances the detection of congenital heart defects and automatically confirms standard fetal heart views, aiming to reduce incomplete scans and false-negative errors. CardioLogs ECG Analysis Platform utilizes deep neural networks for rapid and accurate automated arrhythmia detection, demonstrating high sensitivity and specificity for conditions like AFib.
BrightHeart View Classifier is tailored for prenatal ultrasound exams, focusing on fetal heart views and congenital heart defect screening. CardioLogs ECG Analysis Platform analyzes ECG data from a wide range of cardiac monitoring devices, including Holter monitors, smartwatches, and ECG patches.
BrightHeart View Classifier employs on-site pseudonymization, ensuring no Protected Health Information (PHI) is sent to the BrightHeart cloud. CardioLogs ECG Analysis Platform features data encryption and secure hosting on ISO/IEC 27001 certified AWS servers, with personal data segregated between regions.
BrightHeart View Classifier is designed to ensure exam completeness and consistency regardless of operator experience, suggesting a reduced learning curve for standardized results. CardioLogs ECG Analysis Platform aims to alleviate the burden of redundant ECG analysis tasks, implying a user-friendly design that promotes efficient and consistent analysis.
BrightHeart View Classifier is a cloud-based, plug-and-play solution designed for seamless integration into existing ultrasound workflows, supporting scalability across diverse settings. CardioLogs ECG Analysis Platform is also cloud-based and vendor-neutral, facilitating collaboration and use with multiple compatible recording devices across different facilities.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.